Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-10-27

FDA Approved: OXYBUTYNIN CHLORIDE — Original Application (Advagen Pharma Limited)

View source ↗

Summary

FDA approved the generic oxybutynin chloride tablet from Advagen Pharma Limited under an Original Application.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxybutynin chloride (Oxybutynin chloride)

Snippet

ORIG AP for OXYBUTYNIN CHLORIDE (OXYBUTYNIN CHLORIDE)